The anti-parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice.

Affiliation

Knuplez E(1), Kienzl M(1)(2), Trakaki A(1), Schicho R(1)(2), Heinemann A(1)(2), Sturm EM(1), Marsche G(1)(2).
Author information:
(1)Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
(2)BioTechMed-Graz, Graz, Austria.

Abstract

Erratum in Br J Pharmacol. 2021 May;178(10):2161.